Maryland And Des Plaines

Agreement Significantly Adds to the North American Test Menus of Both Parties and Aims to Increase the Adoption of HPV Screening

Older News

GERMANTOWN, Maryland and DES PLAINES, Illinois, October 12, 2010 - QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and Abbott (ABT: NYSE) today announced that they have entered into an agreement that significantly strengthens both companies' testing menus for automated in-vitro diagnostic applications in the United States and Canada.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy